Assisted, in an independent advisory capacity, Guidepoint Global clients on pharmaceutical and vaccine market research projects.

Led the development and execution of synAllergy’s strategic and tactical sales, marketing, and customer support plans. synAllergy helps primary care practices install and deliver turn key skin allergy testing and immunotherapy services to indicated patients with seasonal allergies.Rebuilt, redesigned, and search engine optimized synAllergy's website which significantly increased web traffic and qualified leads. Expanded synAllergy's team of independent sales professionals. Designed and conducted training sessions for all new contract sales representatives. Designed and managed synAllergy's CRM system (Salesforce.com) to support sales, operations and customer service. Conducted clinical training sessions for physicians and their staff at new customer sites. Initiated, recruited and hired synAllergy's first DNP Clinical Allergy and Immunotherapy Instructor.

Led the business development activities for synAllergy in the Mid-Atlantic Region. Developed synAllergy's new sales, marketing, and pull thru resources. Generated 80% of the company's total revenues through lead generation, service agreement signings and pull through activities.

Led the development and execution of D3 Oncology Solutions'​ sales and marketing plans and the delivery of D3’s solution implementations. Developed D3's new mission statement, marketing strategy, and business plan. Led the re-branding of D3 through the creation of a new company name, new logo (see above), new website, new blog, new collaterals and new display for national meetings. Initiated and installed a new B2B sales model (Solution Selling) and redesigned the architecture of D3's customer relationship management system (Salesforce.com) to align it with the new sales model. D3 is an affiliate of the University of Pittsburgh Medical Center (UPMC) and markets services and products in support of radiation and medical oncology such as IMRT treatment planning, linac commissioning, training, and web-based radiation and medical oncology treatment pathways (Via Oncology).

Co-founded iFitness, Inc. which was established to conduct business as the first franchisee for Koko FitClub in Pennsylvania. Business was closed prematurely due to my co-founder's sudden illness. Despite this setback, it was a great experience as I gained invaluable knowledge of starting a new business via the franchise business model and met many many super business professionals. Koko FitClub is a cutting edge fitness center that offers world-class personal training through technology via their patented SmartTrainer. This technology ensures clients are always doing precisely the right exercise, the right way, at the right pace, for the best possible results. Clients can also view their exercise activity, fitness progress, and next work-out via the web.

See responsibilities below.

Led and directed the promotional sales activities of the Group E Atlantic Coast Region Sales Team with primary accountability for successfully launching Merck's new pharmaceuticals, e.g. Januvia® and Janumet®, and vaccines, e.g. Zostavax®, and Gardasil®. Team was comprised of 10 business managers and 111 representatives located across 7 states. Promoted to Executive Business Director May 1, 2008.

Led and directed the promotional sales activities of the Pennsylvania Region Sales Team with accountability for growing sales and market share for a large portfolio of pharmaceuticals and vaccines. Managed an annual operating budget of $15MM and a region with 16 business managers, 190 professional representatives, and 3 administrative assistants.Initiated and executed Merck's first series of web- based educational program. Piloted numerous new sales resources. Initiated and executed Merck's first region office based minority summer sales internship program.

Special assignment. Led the promotional sales activities of the Philadelphia Region while the director was on child care leave.

Special assignment. Led the integration between the Marketing Team for Cozaar® and Hyzaar® and the primary care, specialty, and hospital sales forces. Responsible for the planning, development, and delivery of the content for semester sales meetings and for all field communications for Cozaar® and Hyzaar®.

Led the Mid-Atlantic Region Cardiovascular and Osteoporosis Specialty Sales Team with accountability for driving sales and market share for Zocor®, Cozaar®, Hyzaar®, and Fosamax®. Also accountable for cardiovascular and osteoporosis market development, e.g. Heart Care Partnership, and advocate development activities.

Led the Southeast Region Business Groups's team of Osteoporosis Market Development Associates and Bone HSAs with accountability for growing sales and market share for Fosamax®. Also accountable for market and advocate development activities.

Hired, trained, the led a newly created team of fifteen Osteoporosis Market Development Associates. District covered the states of NC, KY, and TN. Accountable for growing sales and market share for Fosamax® in addition to market development and advocate development activities.Envisioned, facilitated, and established a first of its kind alliance between Merck and a leading disease management company, previously known as American Healthways, to establish three pilot hospital based osteoporosis diagnostic and treatment centers.

Led newly created and hybrid district sales team with responsibility for growing sales of all Merck products (tablets, injectable antibiotics, e.g. Primaxin® and vaccines, e.g. Recombivax-HB®) in a district comprised of all of the major teaching institutions in North Carolina, e.g. Duke Hospital. Team was comprised of 9 hospital representatives and 1 infectious disease Health Science Associate. Recipient of the 1993 Master’s Club Award and a Management Award for 1994. Promoted to Executive Business Manager June 1, 1995.

Was asked to join the Marketing Team for Proscar® for a special assignment to direct the national launch of the Urinary Symptoms Surveillance Project (USSP). The USSP was a project I created and developed while in the field to help address one of the core barriers to primary care physicians' use of Proscar®. The USSP was very successful in increasing primary care physician's awareness of the prevalence of urinary symptoms in men over age 50 and in accelerating new prescriptions for Proscar®. It was also a first of its kind at Merck and was cited as the most significant contribution to the marketing of Proscar® in 1994.

Led, coached, and managed 9 hospital representatives with responsibility for growing sales for Merck's injectable antibiotics, e.g. Primaxin® and vaccines. District encompassed 4 medical schools and 7 major teaching institutions, e.g. UNC Hospitals, in NC and Eastern VA.

Led, coached, and managed a team of 10 office based professional representatives and one military hospital representative located in SC and Western NC. Directed team to successful launches of Pepcid®, Mevacor®, and Prinivil®.

Supported sales management in recruiting, interviewing, and selecting Merck Sharp & Dohme's professional representatives. Led MSD's MBA recruiting program for non-target graduate schools and the development of the annual region based affirmative action plans.Initiated, developed and implemented Merck's first Minority Summer Sales Internship Program. Envisioned and established a university faculty board of advisors for campus minority recruiting. One of the minority candidates hired thru this program is today one of Merck's VPs.

Planned, developed the content for, and facilitated new product launch meetings (Moduretic®, Dolobid®, Blocadren®, Heptavax-B®, and Indocin SR®), annual meetings, region meetings, and district meetings.

Successfully launched Flexeril®, Clinoril®, Pneumovax®, Timoptic®, and Mefoxin® in a territory in Detroit, MI.